Goldman Sachs reveals 2.87% Qiagen stake
Alpha Vantage · The Globe and Mail · · AI-summarised by FinFlash
Goldman Sachs reported a 2.87% stake in Qiagen via ordinary shares and derivatives, including call options, warrants, swaps, and convertible bonds. The position is held across multiple Goldman Sachs entities. Analysts rate Qiagen (QGEN) a Hold with a $36 price target. The filing increases transparency into Qiagen's shareholder structure amid heightened institutional activity.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.